Syz Capital and Saturnus Capital acquire majority stake in SK Pharma
Zurich — Syz Capital, the private markets investment boutique, today announced the acquisition of a majority stake in SK Pharma Logistics, a provider specializing in the storage, handling, repackaging and distribution of pharmaceutical products. With the support of the Syz family and in close partnership with Saturnus Capital, Syz Capital aims to drive the growth of this strong market leader and accelerate its expansion to ensure the company continues to soar.
SK Pharma is a family-run company based in Bielefeld, Germany, providing services to pharmaceutical companies in Europe and worldwide. The industry leader specializes in pharmaceutical, medical, cosmetic and dietary products. The company’s offering covers the entire logistics value chain and provides complete solutions for customers.
With a compound annual growth rate (CAGR) of 28% over the last three years, the company can look back on remarkable growth that exceeds that of the German healthcare industry over the last ten years by a factor of seven. The company expects further growth as the regulatory environment becomes more stringent and the industry as a whole is expected to grow steadily over the next few years.
Marc Syz, Managing Partner of Syz Capital (photo), says: “We believe this is a unique opportunity to help the family business expand its business and footprint, both through organic growth and acquisitions, and thus consolidate the relatively fragmented sector serving international customers. With SK Pharma, we have indeed found another niche leader, a so-called “hidden champion”, which offers a strong platform for future value creation.
The deal also illustrates the value creation potential for our clients’ portfolios and how Syz Capital is unlocking unique synergy opportunities in private equity and alternative investments.”
Syz Capital is an investment boutique specializing in private markets, offering exclusive access to niche private equity and alternative investments.
Joscha Boehm, Managing Partner of Saturnus Capital and Philipp Schweizer, Partner at Saturnus Capital, who executed this transaction together with Syz Capital, commented, “We look forward to working closely with the founders and the management team to further develop SK Pharma in the coming years. We believe SK Pharma is extremely well positioned as a well-managed company to continue to grow and gain market share.” Saturnus Capital is a private equity firm focusing on mid-market transactions in the DACH region.
The acquisition represents another important milestone for Syz Capital in the family business sector. Both Saturnus and Marc Syz will join SK Pharma’s board, which includes the Krone family and Philippe Milliet, a former member of Galenica’s executive committee and veteran industry veteran.
Stephan Krone, CEO of SK Pharma Logistics GmbH, added: “In our view, Syz Capital and Saturnus Capital, with their extensive experience in investing in family businesses, are the ideal partners to guide SK Pharma through its next growth phase and beyond, creating value for our customers and partners. They have a clear growth strategy for the future. The management team and myself are looking forward to the partnership and to building SK Pharma into a major European player in the logistics sector for the pharmaceutical industry.”
About the Syz Group
Syz Group is a family-owned Swiss financial group that focuses on good long-term investment performance, robust risk management and personalized customer service. In a family of entrepreneurs that has been successful for centuries, the company was co-founded in 1996 by Eric Syz, who now runs it with his two sons and a team of industry experts. Stable and secure — the Syz Group’s equity capitalization is almost double the regulatory requirement in Switzerland.